Diagnosis associated with Tau higher than 1200 pg/mL: Insights from the clinical and laboratory practice
ConclusionThis work emphasizes the interest of a well-thought-out interpretation of CSF biomarkers in neurological diseases, particularly in the case of high Tau protein concentrations in the CSF.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Alzheimer's | Biology | Brain | Dementia | Laboratory Medicine | Neurology | Paraneoplastic Syndrome | Study